936 results on '"MUSOLINO, CATERINA"'
Search Results
202. Prospective validation of predictive value of abdominal computed tomography scan on time to first treatment in Rai 0 chronic lymphocytic leukemia patients: results of the multicenter O-CLL1-GISL study
203. Insulin Growth Factor 1 Receptor Expression Is Associated with NOTCH1 Mutation, Trisomy 12 and Aggressive Clinical Course in Chronic Lymphocytic Leukaemia
204. Efficacy and Safety of a First Line Combined Therapeutic Approach for Young CLL Patients with Advanced or Progressive Disease Stratified According to the Biologic Features: First Analysis of the GIMEMA Multicenter Study LLC0405
205. Insulin Growth Factor 1 Receptor Expression Is Associated with NOTCH1 Mutation, Trisomy 12 and Aggressive Clinical Course in Chronic Lymphocytic Leukemia
206. Updating Long-Term Outcome of Intermittent Imatinib (INTERIM) Treatment in Elderly Patients with Ph+-CML
207. Doublet Vs Triplet Lenalidomide-Containing Regimens in Newly Diagnosed Myeloma Patients, Younger or Older Than 75 Years: Subgroup Analysis of a Phase III Study
208. Gimema Registry of Conception/Pregnancy in Adult Patients Diagnosed with Chronic Myeloid Leukemia (CML) Treated with Tyrosine Kinase Inhibitors (TKIs)
209. Results of high dose of imatinib mesylate in intermediate Sokal risk chronic myeloid leukemia patients in early chronic phase trial of the GIMEMA Working Party
210. TOWARDS A NEED IN OPTIMIZING CML MANAGEMENT IN SUBOPTIMAL RESPONDERS: DATA FROM THE SCREEN REGISTRY
211. Correlazione del polimorfismo genico di MDR-1 con i nuovi marcatori prognostici in pazienti affetti da Leucemia Linfatica Cronica a cellule B
212. Assenza della mutazione JAK2 V617F nel compartimento linfoide di un paziente affetto da trombocitemia essenziale e leucemia linfatica cronica a cellule B ed in due parenti affetti da disordini linfoproliferativi
213. Absence of the V617F JAK2 mutation in the lymphoid compartment in a patient with essential thrombocythemia and B-chronic lymphocytic leukemia and n two relatives with lymphoproliferative disorders
214. MULTIDRUG RESISTANCE-1 GENE POLYMORPHISM ASSOCIATED WITH THE NEW MARKER OF DISEASE PROGRESSION AND POOR PROGNOSIS IN b-CELL CHRONIC LIMPHATIC LEUKEMIA
215. Immunohistochemical evaluation of sarcoglycans and integrin in gingival epithelium of multiple myeloma patients with bisphosphonate-induced osteonecrosis of the jaw
216. Chronic myeloid malignancy as second malignancy: a retrospective multicentric study
217. JAK2 V617F-positive latent essential thrombocythemia and splanchnic vein thrombosis: the role of bone marrow biopsy for the diagnosis of myeloproliferative disease
218. Sarcoglycans and integrins in gingival epithelium during biphosphonates treatment: immunohistochemical study
219. Interleukin-17 reduced serum levels in BRONJ patients after Bisphosphonate administration
220. Patients with bisphosphonate-associated osteonecrosis of the jaw have unmodified levels of soluble vascular endothelial growth factor receptor 1
221. Cellule endoteliali progenitrici circolanti e osteonecrosi mascellare da bifosfonati
222. Angiogenesis in patients with biphosphonate-associated osteonecrosis of the jaw
223. Imatinib mesylate treatment in a patient with chemoresistant Ph+ acute myeloid leukemia: possible role of Wilms' tumor gene 1
224. Evaluation of circulating endothelial progenitor cells in patients with bisphosphonate-associated osteonecrosis of the jaw
225. Circulating endothelial progenitor cells and angiogenic serum factors in patients with chronic myeloproliferative diseases
226. High-dose therapy and autologous peripheral blood stem cells transplantation followed by a very low reduced intensity regimen with fludarabine+cyclophosphamide and allograft improve complete remission rate in de novo multiple myeloma patients
227. Significance of serum interleukin-16 levels in patients with B-cell chronic lymphocytic leukemia
228. Valutazione della concentrazione di precursori circolanti delle cellule endoteliali in corso di gravidanza normale ed in gravide affette da diabete gestazionale ed insufficienza gravidica
229. Serum levels of Interleukin-16 as an important prognostic factor in multiple Myeloma patient with cutaneous involvement
230. Immature myeloid-derived suppressor cells: A bridge between inflammation and cancer (Review).
231. Elevated srum concentration of angiopoietin-2 in patients with multiple myeloma: correlation with markers of disease
232. Serum levels of angiopoietin-2 and its receptor TIE2 in Chronic myeloproliferative disease
233. Purpuric gloves and socks sindrome caused by parvovirus B19 infection
234. Reinfusion of autologous lymphocytes with granulocyte-macrophage coloni stimulating factor induces rapid recovery of CD4+ and CD8+ T-cells after high dose chemotherapy for multiple myeloma
235. Prognostic significance of immunophenotype in chronic lymphocytic leukaemia
236. Infectious complications in multiple myeloma patients undergoing autologous stem cell transplantation after high dose melphalan: a single centre retrospective analysis towards outpatients strategy
237. Low-energy laser irradiation promotes cellular damage in glucocorticoid-resistant multiple myeloma cells
238. The Cancer Stem Cell Hypothesis: A Guide to Potential Molecular Targets
239. Is ZAP70 still a key prognostic factor in early stage chronic lymphocytic leukaemia? Results of the analysis from a prospective multicentre observational study
240. Effect of therapeutic plasma exchange on plasma levels of oxidative biomarkers in a patient with thrombotic thrombocytopenic purpura
241. Association of osteonecrosis of the jaws and POEMS syndrome in a patient assuming rituximab
242. Long-Term Results in Multiple Myeloma After High-Dose Melphalan and Autologous Transplantation According to Response Categories in the Era of Old Drugs
243. MiRNome expression is deregulated in the peripheral lymphoid compartment of multiple myeloma
244. High-throughput sequencing for the identification ofNOTCH1mutations in early stage chronic lymphocytic leukaemia: biological and clinical implications
245. Fludarabine plus alemtuzumab (FA) front-line treatment in young patients with chronic lymphocytic leukemia (CLL) and an adverse biologic profile
246. New orally active proteasome inhibitors in multiple myeloma
247. Severe progressive sensorimotor polyneuropathy in a patient with osteosclerotic myeloma and MRI evidence of meningeal involvement
248. EVALUATION OF DECORIN AND BIGLYCAN GENE EXPRESSION IN LYMPHOCYTES FROM PATIENTS WITH CHRONIC LYMPHATIC LEUKAEMIA
249. Lipid profile in hematologic neoplasms
250. METHYMAZOLE-INDUCED AGRANULOCYTOSIS AND QUICK RECOVERY WITH G-CSF: CARE REPORT
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.